PMDA drug package insert
パプトン鼻炎カプセルM
PMDA OTC drug · 田村薬品工業（株） · package insert Jun 14, 2022
Key facts
| Brand names | パプトン鼻炎カプセルM |
|---|---|
| Companies | 製造販売元／田村薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | 鼻炎用内服薬 |
| Package insert date | Jun 14, 2022 |
| PMDA document key | 400348_J0701000493 |
| PMDA company code | 400348 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: